Clinical Trial Update: Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial assessing bortezomib with cetuximab and radiation therapy, with or without cisplatin, in stage IV head and neck cancer; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Platinol (cisplatin)
• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED